WO2000018254A2 - Method of protecting heat- or oxygen-labile compounds to preserve activity and bioavailability - Google Patents

Method of protecting heat- or oxygen-labile compounds to preserve activity and bioavailability Download PDF

Info

Publication number
WO2000018254A2
WO2000018254A2 PCT/US1999/022427 US9922427W WO0018254A2 WO 2000018254 A2 WO2000018254 A2 WO 2000018254A2 US 9922427 W US9922427 W US 9922427W WO 0018254 A2 WO0018254 A2 WO 0018254A2
Authority
WO
WIPO (PCT)
Prior art keywords
compound
oxygen
solution
labile
heat
Prior art date
Application number
PCT/US1999/022427
Other languages
French (fr)
Other versions
WO2000018254A3 (en
Inventor
Douglas Howard Catron
James Oscar Mann
Original Assignee
Kemin Industries, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/307,414 external-priority patent/US6146671A/en
Application filed by Kemin Industries, Inc. filed Critical Kemin Industries, Inc.
Priority to AU61655/99A priority Critical patent/AU758534B2/en
Priority to BR9914070-5A priority patent/BR9914070A/en
Priority to JP2000571780A priority patent/JP3605360B2/en
Priority to EP99948490A priority patent/EP1115295A4/en
Publication of WO2000018254A2 publication Critical patent/WO2000018254A2/en
Publication of WO2000018254A3 publication Critical patent/WO2000018254A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K40/00Shaping or working-up of animal feeding-stuffs
    • A23K40/30Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/256Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/275Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
    • A23L29/281Proteins, e.g. gelatin or collagen
    • A23L29/284Gelatin; Collagen
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/30Encapsulation of particles, e.g. foodstuff additives

Definitions

  • the invention relates to a method of protecting heat-labile and/or oxygen-labile compounds and, more specifically, to heat- and/or oxygen-labile compounds that are coated to protect the activity of the compounds or the labile component of a food or feedstuff, particularly following extrusion, without sacrificing the bioavailability of the compounds upon ingestion 2 Background of the Art
  • Encapsulation of the active compounds protects them against oxygen degradation not only through physical protection from contact with oxygen, but also by protecting them against interaction with oxidizing agents and free-radical initiators that may be present in the substrate, such as a food product, to which the encapsulated compounds have been added
  • oxidizing agents and free-radical initiators that may be present in the substrate, such as a food product, to which the encapsulated compounds have been added
  • polyvalent metal ions such as iron, copper, manganese, and chromium
  • the presence of these oxidizing agents ordinarily accelerates the oxygen degradation of the unprotected active compounds, particularly if elevated temperatures or pressures are present
  • encapsulation of the active compounds will protect them from radical initiators
  • encapsulation of the active compounds serves another purpose Certain of these active compounds, such as lutein, are not oxidizing agents or free-radical initiators themselves, but upon degradation become oxidizing agents or free-radical initiators.
  • the process of coating of the known oxidizing agents or free-radical initiators that may be added to the product containing the labile compounds.
  • the process of the present invention may be used either directly to protect the labile compounds themselves or indirectly by limiting the activity of oxidizing agents and free-radical initiators.
  • the compounds, either the labile compounds or the oxidizing agents or free-radical initiators, or both, being added to the product are subject to coating to provide the protective effect.
  • the invention consists of a method of encapsulating heat- and/or oxygen-labile compounds with a protective coating that will limit the loss in activity of the compound during processing, particularly extrusion, and storage of a food product containing the encapsulated compound while maintaining a high degree of bioavailability of the compound throughout the shelf life of the food product and when the food product is ingested.
  • oxidizing agents or free-radical initiators including compounds which release or become such oxidizing agents or free-radical initiators upon degradation, are encapsulated with a protective coating.
  • the invention allows for the supplementation of food products with heat- and/or oxygen labile compounds in combination with other desirable supplements, such as minerals, which are normally antagonistic.
  • An aqueous solution of sodium alginate is prepared and the compound to be protected is added.
  • One or more ancillary polymeric compound such as carrageenan, locust bean gum, and gelatin are used to improve the encapsulation.
  • the solution is sprayed onto a bath of calcium chloride solution, forming calcium alginate beadlets in which are dispersed a volume of the solution including the protected compound.
  • the beadlets are separated and dried.
  • the beadlets exhibit enhanced stability of the protected compounds through the extrusion process.
  • Fig. 1 is a graphical representation of the loss in lutein and ⁇ -carotene at various
  • Fig. 2 is a graphical representation of oxygen absorption of beadlets protected by gelatin and the process of the present invention.
  • Fig. 3 is a graphical representation of the levels of lutein remaining in beadlets of the lutein and protected by highly cross-linked gelatin, 50% cross-linked gelatin, and the process of the present invention before and after exposure to 50 psi oxygen in an oxygen bomb at standard temperature for 100 hours.
  • the piesent method of forming encapsulated biologically active compounds compnses the steps of dissolving sodium algmate in water at room temperatui e to produce a solution of sodium algmate Added to the solution is an ancillary polymeric compound, such as gelatin Other ancillary polymeric agents, such as carrageenan, locust bean gum, guar gum, or the like may be added to the solution or substituted in whole or m part for the gelatin
  • the biologically active compound(s) are also added to the solution
  • the mixture is sprayed onto an aqueous bath having a source of calcium ions, such as dissolved calcium chloride
  • the beadlets that aie formed are filteied out of the solution and dried
  • the ranges of the sodium alginate, ancillary polymeric mate ⁇ al(s), and biologically active compound(s) to be added m the solution are provided on a total dry mattei weight basis
  • Amounts of algmate less than the recited range do not lesult in satisfactory beadlet formation
  • Amounts of algmate in excess of the recited range do not have satisfactory oxygen impermeability
  • Amounts of gelatin less than the recited range result in a beadlet with unsatisfactory oxygen permeability and amounts m excess of the recited range mterfei e with formation of the algmate web or substrate
  • Amounts of the biologically active compound(s) below the recited range will not adversely affect the effectiveness of protecting and dehveimg a biologically available compound, but are not likely to be commercially feasible in that an excess amount of protective mate ⁇ al is utilized
  • Amounts of the biologically active compound(s) greater than the recited range may mterfei e with formation of an effectively protective beadlet and will adveisely affect the economy of the piocess by increasing the amount of the active compound(s) that is lost dining processing and storage
  • the ratio of water to dry ingredients used in the solution necessarily depends on the particular one or combination of ancillary polymeric compounds that are used
  • carrageenan is consideiably more viscous at lower concentrations than gelatin
  • the ratio falls within a range of between about 15 1 and about 7 1 , watei dry ingiedients, with a preferred range of between about 12 1 and about 8 1 If less than the lecited range of water is used, the viscosity of the solution will start to prevent effective pumping and/oi spraying of the solution If greater than the recited range of water is used, it is difficult to form discrete beadlets
  • lutein a carotenoid that is believed to have immune system stimulating effects in dogs, to protect the lutein against degradation du ⁇ ng the extrusion piocess and throughout the shelf life of a food product without adversely affecting its bioavailability upon ingestion of the food product
  • Alginate commercially available as alginic acid, sodium salt, commonly called sodium algmate, is a linear polysaccha ⁇ de normally isolated from marine brown seaweed and algae
  • the copolymer consists of two uromc acids D-mannuronic acid and L-guluromc acid Alginic acid can be either water soluble oi insoluble depending on the type of the associated salt
  • the salts of sodium, other alkali metals, and ammonia are soluble, whereas the salts of polyvalent cations, e g , calcium, are water insoluble
  • Polyvalent cations bind to the polymer whenevei there aie two neighbo ⁇ ng guluronic acid residues Accordingly, the polyvalent cations are responsible for the cross-linkmg of both different polymer molecules and different parts of the same polymer chain
  • the exchange of calcium ions for sodium ions is carried out under relatively mild conditions In that the method of gelation is based on the availability of guluronic acid residues,
  • samples of lutein encapsulated m highly cross-linked gelatin and m model ately cross-lmked gelatin were also prepared according to the following methods A 1000 g sample of FloiaGLO ® 20% Liquid (Kemm Foods) was prepared using the disk method Shell material solutions were made using 25% Gelatin Bloom 300 and 5%
  • microspheres were collected on cornstarch, allowed to dry and then sieved After the microspheres were collected, they were cross-linked using glutaraldehyde at 5% of the total weight of gelatin Glutaraldehyde, ethanol and water were combined in the ration of 1 8 1 to prepare the cross-linkmg solution
  • the microspheres weie added to the solution and allowed to cross-lmk for an hour They were placed in a water bath and heated for 10 minutes, then harvested and dried
  • the resulting extruded product has an initial moisture content of about 25% and is dried between about 15 and 30 minutes at a temperature
  • Beta-Carotene 10% from Roche (identified as having beta-carotene finely dispersed in a starch-coated matrix of gelatin and carbohydrates), Beta-Carotene 1 % B from Roche (identified as having beta-carotene finely dispersed in a starch-coated matrix of fish gelatin, fructose, glycerol), and Lucarotin® from BASF (identified as special food-grade beta-carotene containing a minimum of 7% beta-carotene)
  • Fig 1 shows the stability of the lutein in the control and by encapsulation using the three techniques
  • Oxygen permeability of the three encapsulated lutein products was tested by in an oxygen bomb under 50 psi oxygen for 100 hours with the oxygen bomb kept at room temperature during analysis The results of the tests are set out in Fig 2 and are summarized in Table 1 and Fig 3
  • Calcium alginate is a non-thermally reversible and water insoluble polymer
  • the gelatin added to the alginate in the present invention does not chemically react with the alginate, either sodium or calcium alginate There is, however, believed to be a degree of physical binding that occurs as the gelatin thermally folds and the alginate cross-links The physical binding that occurs as the gelatin thermally folds and the alginate cross-links.
  • the beadlets that are produced are a solid dispersion of the lutein in the encapsulating material.
  • the small amount of loss of lutein observed in beadlets of the present invention is believed to be due to surface crystals of lutein that are only thinly covered by the encapsulating material.
  • a stabilizing compound, such as an antioxidant may be added to the heat- and/or oxygen- labile compound prior to its addition to the solution of protecting materials to protect further the labile compound.
  • the active compound is not chemically altered by the encapsulation process.
  • the crystalline lutein used in the specific embodiments is not changed by the process. Throughout the encapsulation process and extrusion of a food product to which the beadlets of encapsulated lutein have been added, the lutein is still present as the discrete lutein crystals that are present in the starting material.
  • the amount of sodium alginate can be adjusted through a range to achieve the results desired in specific applications.
  • concentration of ancillary polymeric compounds may not be critical for a given application. While gelatin is the preferred ancillary polymeric
  • polymeric materials that could be used either alone or in combination with gelatin or each other include albumin, casein or other proteins, carrageenan, guar gum, xanthan gum, or other polysaccharides.

Abstract

A method for protecting the activity and bioavailability of heat- and/or oxygen-labile compounds during processing, particularly processing by extrusion of a food product containing the heat- and/or oxygen-labile compounds. Beadlets are formed wherein the heat- and/or oxygen-labile compound is protected by a shell of calcium alginate and an ancillary polymeric compound, such as gelatin. The beadlets are added to a food product prior to extrusion and protect the active compound against heat degradation during the extrusion process. The beadlets also provide a protected form of the compound that decreases oxidation. In an alternative embodiment, oxidizing agents and/or free radical initiators to be added to a product containing labile compounds are coated with the proctective material to protect the labile compounds from degradation by the oxidizing agents and/or free-radical initiators.

Description

METHOD OF PROTECTING HEAT- OR OXYGEN-LABILE COMPOUNDS TO PRESERVE ACTIVITY AND BIOAVAILABILITY
Background of the Invention 1 Field of the Invention The invention relates to a method of protecting heat-labile and/or oxygen-labile compounds and, more specifically, to heat- and/or oxygen-labile compounds that are coated to protect the activity of the compounds or the labile component of a food or feedstuff, particularly following extrusion, without sacrificing the bioavailability of the compounds upon ingestion 2 Background of the Art
Many biologically important compounds lose activity if exposed to heat or oxygen, wherein the heat or oxygen lability of the compounds may be related to the degree of unsaturation, i e , the presence of double bonds, of the compounds Such compounds include many of the vitamins Also included are antioxidants Numerous attempts have been made in an effort to stabilize these compounds so that the activity of the compounds is maintained over longer periods of time upon exposure to heat and/or oxygen Certain of these methods have focused on coating of the compounds with a protective material, including gelatin and alginate Protecting the compounds against degradation is not the only concern, however The protected compounds must also be available for biological absorption upon ingestion These two purposes are inherently conflicting in that known methods of protection of the compounds during processing and storage have also limited or prevented absorption of the compounds so that less of the biologically important compound is effectively delivered to the ingesting organism
One of the major uses of these heat- and/or oxygen-labile compounds is m the supplementation of food, including both human food and animal feed. Ambient temperatures and storage conditions typically lead to a loss of activity of the compounds over time frames that are usually shorter than the other limiting times for most foods. While the use of sealed containers and low -temperature storage ameliorates the degradation of the compounds, these methods are expensive and often not practical. Many food processing methods use heat which further reduces the level of active heat-labile and oxygen-labile compounds. A particularly common and destructive food processing method is extrusion, a process that involves aggressive comminuting of the food product under extreme temperatures and pressures. Extrusion is used in the commercial production of almost all dry pet foods, and is very common in the production of ready-to-eat cereals. Recent studies have shown in excess of 60% sacrifice of carotenoids through extrusion processing. Addition of the compounds after extrusion leaves the compounds more susceptible to oxidation due to oxygen in the atmosphere and results in visual detection of the compound on the surface of the food product. Application is also difficult because of product wicking of the surface of the extruded diet which results in active ingredients being transferred to the sides of the container in which the diet is stored.
Attempts to encapsulate biologically active compounds using gelatin have had mixed results. To be an effective coating, the gelatin must be extensively cross-linked. Unfortunately, cross-linked gelatin is not readily dissolved in the digestive tract. Accordingly, while increasing the cross-linking of the gelatin increases its protective qualities, it decreases the bioavailability of the protected compound. Various forms of alginate have been used in a variety of encapsulation techniques. One such technique involves dissolving sodium alginate in water, adding the "payload" compound to be protected, and spraying the solution into a bath containing calcium ions. As the droplets enter the bath, the soluble sodium alginate is rapidly converted into insoluble calcium alginate, effectively encapsulating the "payload" compound The calcium alginate beadlets are digested by ionic exchange with other salts during digestion However, the use of calcium alginate alone produces a beadlet that is substantially oxygen permeable Tests on calcium alginate by Southwest Research Institute are that oxygen permeability of a calcium alginate membrane at standard temperature and pressure is 2 91 x 1011 cm cm3 /cm2 s (cm
Hg).
The only option in the known prior art is to over- formulate the liable components that are included in the food or feedstuff This over-formulation adds unnecessary expense and does not guarantee product performance Neither alginate or gelatin beadlets have provided both adequate protection and bioavailability of the encapsulated compounds
Encapsulation of the active compounds protects them against oxygen degradation not only through physical protection from contact with oxygen, but also by protecting them against interaction with oxidizing agents and free-radical initiators that may be present in the substrate, such as a food product, to which the encapsulated compounds have been added For example, polyvalent metal ions, such as iron, copper, manganese, and chromium, are active oxidizing agents and are also present in food products, particularly food products that have been supplemented with such minerals for improved nutritional characteristics The presence of these oxidizing agents ordinarily accelerates the oxygen degradation of the unprotected active compounds, particularly if elevated temperatures or pressures are present In a similar fashion, encapsulation of the active compounds will protect them from radical initiators In this regard, encapsulation of the active compounds serves another purpose Certain of these active compounds, such as lutein, are not oxidizing agents or free-radical initiators themselves, but upon degradation become oxidizing agents or free-radical initiators. Alternatively to coating the labile compounds, or supplementary thereto, is the process of coating of the known oxidizing agents or free-radical initiators that may be added to the product containing the labile compounds. For example, if polyvalent metals are to be added to a food product containing labile compounds, coating of the metals by the process of the present invention will serve to limit the degenerative effect that such substances may have on the labile compounds. In this way, the process of the present invention may be used either directly to protect the labile compounds themselves or indirectly by limiting the activity of oxidizing agents and free-radical initiators. In practical application, the compounds, either the labile compounds or the oxidizing agents or free-radical initiators, or both, being added to the product are subject to coating to provide the protective effect.
There is a need for a method for encapsulating heat- and/or oxygen-labile compounds, or oxidizing agents and free-radical initiators, or both, that will effectively protect labile compounds that have been added or that may otherwise be present from degradation and loss of activity, particularly through the extremely harsh extrusion process, while maintaining the bioavailability of the labile compounds upon ingestion after extrusion.
Summary of the Invention The invention consists of a method of encapsulating heat- and/or oxygen-labile compounds with a protective coating that will limit the loss in activity of the compound during processing, particularly extrusion, and storage of a food product containing the encapsulated compound while maintaining a high degree of bioavailability of the compound throughout the shelf life of the food product and when the food product is ingested. In an alternative embodiment, oxidizing agents or free-radical initiators, including compounds which release or become such oxidizing agents or free-radical initiators upon degradation, are encapsulated with a protective coating. The invention allows for the supplementation of food products with heat- and/or oxygen labile compounds in combination with other desirable supplements, such as minerals, which are normally antagonistic.
An aqueous solution of sodium alginate is prepared and the compound to be protected is added. One or more ancillary polymeric compound such as carrageenan, locust bean gum, and gelatin are used to improve the encapsulation. The solution is sprayed onto a bath of calcium chloride solution, forming calcium alginate beadlets in which are dispersed a volume of the solution including the protected compound. The beadlets are separated and dried. The beadlets exhibit enhanced stability of the protected compounds through the extrusion process.
Brief Description of the Drawings
Fig. 1 is a graphical representation of the loss in lutein and β-carotene at various
points throughout the extrusion process of a food product which included beadlets of the
lutein and a food product which included beadlets of the β-carotene and protected by gelatin and the process of the present invention.
Fig. 2 is a graphical representation of oxygen absorption of beadlets protected by gelatin and the process of the present invention.
Fig. 3 is a graphical representation of the levels of lutein remaining in beadlets of the lutein and protected by highly cross-linked gelatin, 50% cross-linked gelatin, and the process of the present invention before and after exposure to 50 psi oxygen in an oxygen bomb at standard temperature for 100 hours.
HEET RUIE28) Detailed Description of a Preferred Embodiment The piesent method of forming encapsulated biologically active compounds compnses the steps of dissolving sodium algmate in water at room temperatui e to produce a solution of sodium algmate Added to the solution is an ancillary polymeric compound, such as gelatin Other ancillary polymeric agents, such as carrageenan, locust bean gum, guar gum, or the like may be added to the solution or substituted in whole or m part for the gelatin The biologically active compound(s) are also added to the solution The mixture is sprayed onto an aqueous bath having a source of calcium ions, such as dissolved calcium chloride The beadlets that aie formed are filteied out of the solution and dried The ranges of the sodium alginate, ancillary polymeric mateπal(s), and biologically active compound(s) to be added m the solution are provided on a total dry mattei weight basis The range of sodium algmate is between about 5% and about 90%, the range of ancillary polymeric mateπal(s) is between about 5% and about 90%, and the range of biologically active mateπal(s) is between about 5% and about 50% Preferably, the range of sodium alginate is between about 30% and about 45%, the range of ancillary polymeiic mateπal(s) is between about 30% and about 45%, and the lange of biologically active mateπal(s) is between about 10% and about 40% Most preferably, appi oximately equal weights of sodium algmate and ancillary polymeric material aie used m combination with somewhat less than an equal amount of the biologically active material In the preferred embodiment set out below, the weight ratio of sodium algmate ancillary polymeric mateπal biologically active material is approximately 9 10 6, or 1 5 1 67 1
Amounts of algmate less than the recited range do not lesult in satisfactory beadlet formation Amounts of algmate in excess of the recited range do not have satisfactory oxygen impermeability Amounts of gelatin less than the recited range result in a beadlet with unsatisfactory oxygen permeability and amounts m excess of the recited range mterfei e with formation of the algmate web or substrate Amounts of the biologically active compound(s) below the recited range will not adversely affect the effectiveness of protecting and dehveimg a biologically available compound, but are not likely to be commercially feasible in that an excess amount of protective mateπal is utilized Amounts of the biologically active compound(s) greater than the recited range may mterfei e with formation of an effectively protective beadlet and will adveisely affect the economy of the piocess by increasing the amount of the active compound(s) that is lost dining processing and storage
The ratio of water to dry ingredients used in the solution necessarily depends on the particular one or combination of ancillary polymeric compounds that are used For example, carrageenan is consideiably more viscous at lower concentrations than gelatin Generally, the ratio falls within a range of between about 15 1 and about 7 1 , watei dry ingiedients, with a preferred range of between about 12 1 and about 8 1 If less than the lecited range of water is used, the viscosity of the solution will start to prevent effective pumping and/oi spraying of the solution If greater than the recited range of water is used, it is difficult to form discrete beadlets
Expenments weie initiated to develop an encapsulation technique for lutein, a carotenoid that is believed to have immune system stimulating effects in dogs, to protect the lutein against degradation duπng the extrusion piocess and throughout the shelf life of a food product without adversely affecting its bioavailability upon ingestion of the food product
Alginate, commercially available as alginic acid, sodium salt, commonly called sodium algmate, is a linear polysacchaπde normally isolated from marine brown seaweed and algae The copolymer consists of two uromc acids D-mannuronic acid and L-guluromc acid Alginic acid can be either water soluble oi insoluble depending on the type of the associated salt The salts of sodium, other alkali metals, and ammonia are soluble, whereas the salts of polyvalent cations, e g , calcium, are water insoluble Polyvalent cations bind to the polymer whenevei there aie two neighboπng guluronic acid residues Accordingly, the polyvalent cations are responsible for the cross-linkmg of both different polymer molecules and different parts of the same polymer chain The exchange of calcium ions for sodium ions is carried out under relatively mild conditions In that the method of gelation is based on the availability of guluronic acid residues, and these residues do not vary from the initial conditions in a batch of the algmate, the molecular permeability (poi e size) of a pure algmate gel does not depend on the immobilization conditions, but rather is controlled by the choice of the starting material
Experiments were initiated to develop an encapsulation technique for lutein, a carotenoid that is believed to have immune system stimulating effects in dogs, to protect the lutem against degradation duπng the extrusion piocess and throughout the shelf life of a food product without adversely affecting its bioavailability upon ingestion of the food product An encapsulated product was pioduced using the following method An aqueous solution of sodium algmate is prepared using 320 ml water and 10 g sodium algmate Added to the solution was 6 666 g of FloraGLO Lutem Crystalline Dry, a commercially available (Kemin Foods, L C , Des Moines, Iowa) source of lutein produced under U S Patent No 5.648,564, containing 80%> lutem by weight Also added was 0 005 ml of Naturox™ Liquid (Kemm Industries), 0 1 g locust bean gum, 10 0 g gelatin, and 1 0 g carrageenan This mixture was sprayed onto an aqueous bath of 5% calcium chloride The beadlets that formed
were then filtered, dried in a convection oven at between 60 °C and 80°C until essentially no
more moisture was being withdrawn, and mixed with cornstarch until the lutein content was 6 1 % by weight Foi comparison purposes, samples of lutein encapsulated m highly cross-linked gelatin and m model ately cross-lmked gelatin were also prepared according to the following methods A 1000 g sample of FloiaGLO® 20% Liquid (Kemm Foods) was prepared using the disk method Shell material solutions were made using 25% Gelatin Bloom 300 and 5%
Sorbitol in 70% water, then heated to approximately 55 °C After the shell material reached
the desired temperature, 40% of the FloraGLO® was added to provide 5% theoretical payload and mixed to form a dispersion The dispersion was then pumped at approximately 50 g/mm onto a disk rotating at approximately 2000 RPM which created miciospheies with a size range of 200 - 900 miciometers, with an average range of 500 - 700 micrometers The
reservou, pump, lines, disk, and material were all maintained at approximately 50 - 55 °C
The microspheres were collected on cornstarch, allowed to dry and then sieved After the microspheres were collected, they were cross-linked using glutaraldehyde at 5% of the total weight of gelatin Glutaraldehyde, ethanol and water were combined in the ration of 1 8 1 to prepare the cross-linkmg solution The microspheres weie added to the solution and allowed to cross-lmk for an hour They were placed in a water bath and heated for 10 minutes, then harvested and dried
As a control, FloraGLO® 5% Dry (Kemm Foods), a form of lutein encapsulated m non-cross-linked gelatin, was also used Samples of each of the four products were added to a commercial dog food formulation prior to extrusion and then processed by extrusion under
conditions of temperatures between about 250 °F and 300 °F, pressure of approximately 600
psi for between about 20 and 60 seconds The resulting extruded product has an initial moisture content of about 25% and is dried between about 15 and 30 minutes at a temperature
between about 200 °F and 250 °F to dry it to between 8 and 10% moisture
For further comparison purposes, commercially available forms of encapsulated β- carotene were evaluated throughout the extrusion process The encapsulated β-carotene
products were Rovimix® Beta-Carotene 10% from Roche (identified as having beta-carotene finely dispersed in a starch-coated matrix of gelatin and carbohydrates), Beta-Carotene 1 % B from Roche (identified as having beta-carotene finely dispersed in a starch-coated matrix of fish gelatin, fructose, glycerol), and Lucarotin® from BASF (identified as special food-grade beta-carotene containing a minimum of 7% beta-carotene)
Samples of the food product were taken throughout the process for analysis Fig 1 shows the stability of the lutein in the control and by encapsulation using the three techniques
and the encapsulated β-carotene from the three commercial sources Some variation in the
data was observed due to the relatively small concentration (between about 60 g and about 600g) of the encapsulated products that were incorporated in the dog food (one ton batches) The alginate protected lutein showed a surprising amount of stability
Oxygen permeability of the three encapsulated lutein products was tested by in an oxygen bomb under 50 psi oxygen for 100 hours with the oxygen bomb kept at room temperature during analysis The results of the tests are set out in Fig 2 and are summarized in Table 1 and Fig 3
TABLE 1
Figure imgf000012_0001
Calcium alginate is a non-thermally reversible and water insoluble polymer The gelatin added to the alginate in the present invention does not chemically react with the alginate, either sodium or calcium alginate There is, however, believed to be a degree of physical binding that occurs as the gelatin thermally folds and the alginate cross-links The physical binding that occurs as the gelatin thermally folds and the alginate cross-links. The beadlets that are produced are a solid dispersion of the lutein in the encapsulating material. The small amount of loss of lutein observed in beadlets of the present invention is believed to be due to surface crystals of lutein that are only thinly covered by the encapsulating material. A stabilizing compound, such as an antioxidant, may be added to the heat- and/or oxygen- labile compound prior to its addition to the solution of protecting materials to protect further the labile compound.
It is important to note that the active compound, provided it is not overly reactive with calcium ions, is not chemically altered by the encapsulation process. In particular, the crystalline lutein used in the specific embodiments is not changed by the process. Throughout the encapsulation process and extrusion of a food product to which the beadlets of encapsulated lutein have been added, the lutein is still present as the discrete lutein crystals that are present in the starting material.
The amount of sodium alginate can be adjusted through a range to achieve the results desired in specific applications. The concentration of ancillary polymeric compounds may not be critical for a given application. While gelatin is the preferred ancillary polymeric
material, other polymeric materials that could be used either alone or in combination with gelatin or each other include albumin, casein or other proteins, carrageenan, guar gum, xanthan gum, or other polysaccharides.
Although the invention has been described with respect to a preferred embodiment thereof, it is to be also understood that it is not to be so limited since changes and modifications can be made therein which are within the full intended scope of this invention as defined by the appended claims.

Claims

We claim:
1. A method of protecting heat- and/or oxygen-labile compounds, comprising the steps of: a. preparing an aqueous solution of an alkali metal salt of alginate; b. adding to said solution a polymeric compound selected from the group including gelatin, albumin, casein or other proteins, carrageenan, guar gum, xanthan gum, or other polysaccharides; c. adding to said solution a heat- and/or oxygen-labile compound; d. directing droplets of said solution into a source of calcium ions to form beadlets of said heat- and/or oxygen-labile compound dispersed within a matrix of calcium alginate and said polymeric compound.
2 The method of claim 1 , wherein the heat- and/or oxygen-labile compound is selected from the group including carotenoids, vitamins, and enzymes
3 The method of claim 1 , further comprising the step of adding a stabilizing agent to the heat- and/or oxygen-labile compound prior to the step of adding the labile compound to the solution
4 The method of claim 3, wherein the stabilizing agent is an antioxidant
5 The method of claim 1 , wherein the alkali metal is sodium
A method of protecting heat- and/or oxygen-labile compounds from degradation by oxidizing agents and/or free-radical initiators, comprising the steps of a preparing an aqueous solution of an alkali salt of alginate, b adding to said solution a polymeric compound selected from the group including gelatin, albumin, casein or other proteins, carrageenan, guar gum, xanthan gum, or other polysaccharides, c adding to said solution an oxidizing agent and/or free-radical initiator, d directing droplets of said solution into a source of calcium ions to form beadlets of said oxidizing agent and/or free-radical initiator dispersed within a matrix of calcium alginate and said polymeπc compound
7. The method of claim 6, wherein the oxidizing agent and/or free-radical initiator is a compound which releases polyvalent metal ions in solution.
8. The method of claim 6, further comprising the step of adding a stabilizing agent to the oxidizing agent and/or free-radical initiator prior to the step of adding the compound to the solution.
The method of claim 6, wherein the alkali metal is sodium.
10. A feedstuff for an organism, comprising: a. a feedstuff substrate which will be processed and stored prior to ingestion by the organism; b. a feedstuff supplement compound; and c. a protective coating applied to the supplement compound prior to addition of the supplement compound to the feedstuff substrate to protect the supplement compound from degradation during processing and storage of the feedstuff and which is degraded upon ingestion of the feedstuff by the organism to release the feedstuff supplement.
11. A feedstuff as defined in claim 10, wherein said protective coating is a mixture of calcium alginate and an ancillary polymeric material selected from the group including gelatin, albumin, casein or other proteins, carrageenan, guar gum, xanthan gum, or other polysaccharides.
PCT/US1999/022427 1998-09-25 1999-09-24 Method of protecting heat- or oxygen-labile compounds to preserve activity and bioavailability WO2000018254A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU61655/99A AU758534B2 (en) 1998-09-25 1999-09-24 Method of protecting heat- or oxygen-labile compounds to preserve activity and bioavailability
BR9914070-5A BR9914070A (en) 1998-09-25 1999-09-24 Method of protecting compounds labile to oxygen and / or heat, and against degradation by oxidizing agents and / or free radical initiators, and, feed to an organism
JP2000571780A JP3605360B2 (en) 1998-09-25 1999-09-24 A method for protecting heat- or oxygen-labile compounds to maintain activity and bioavailability.
EP99948490A EP1115295A4 (en) 1998-09-25 1999-09-24 Method of protecting heat- or oxygen-labile compounds to preserve activity and bioavailability

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10180398P 1998-09-25 1998-09-25
US60/101,803 1998-09-25
US09/307,414 1999-05-08
US09/307,414 US6146671A (en) 1999-05-08 1999-05-08 Method and protecting heat-or oxygen-labile compounds to preserve activity and bioavailability

Publications (2)

Publication Number Publication Date
WO2000018254A2 true WO2000018254A2 (en) 2000-04-06
WO2000018254A3 WO2000018254A3 (en) 2000-05-25

Family

ID=26798648

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/022427 WO2000018254A2 (en) 1998-09-25 1999-09-24 Method of protecting heat- or oxygen-labile compounds to preserve activity and bioavailability

Country Status (5)

Country Link
EP (1) EP1115295A4 (en)
JP (1) JP3605360B2 (en)
AU (1) AU758534B2 (en)
BR (1) BR9914070A (en)
WO (1) WO2000018254A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007023223A1 (en) * 2005-08-25 2007-03-01 Virbac Sa Product for the preparation of enriched animal feed
WO2008087608A1 (en) * 2007-01-19 2008-07-24 The Iams Company Composition and method of stabilized sensitive ingredient
CN109265711A (en) * 2018-09-03 2019-01-25 胡权 A kind of preparation method of polymer particle
US11388914B2 (en) 2015-04-28 2022-07-19 Mars, Incorporated Process of preparing a wet pet food, wet pet food produced by the process and uses thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201343203A (en) 2011-12-22 2013-11-01 Pronova Biopharma Norge As Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof
MY169231A (en) * 2013-03-28 2019-03-19 Dsm Ip Assets Bv Lutein composition suitable for infant food formulations

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389419A (en) * 1980-11-10 1983-06-21 Damon Corporation Vitamin encapsulation
US5356636A (en) * 1991-12-14 1994-10-18 Basf Aktiengesellschaft Stable vitamin and/or carotenoid products in powder form, and the preparation thereof
US5427935A (en) * 1987-07-24 1995-06-27 The Regents Of The University Of Michigan Hybrid membrane bead and process for encapsulating materials in semi-permeable hybrid membranes
EP0689834A2 (en) * 1994-07-01 1996-01-03 Willem Jacob Serfontein Sustained release food or feed supplement containing vitamins and minerals

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211980A (en) * 1980-10-03 1993-05-18 Cox James P Lipid pelletization methods, apparatus and products
JPS6121070A (en) * 1984-07-11 1986-01-29 Q P Corp Food similar to fish roe and its preparation
US4695463A (en) * 1985-05-24 1987-09-22 Warner-Lambert Company Delivery system for active ingredients and preparation thereof
GB8522963D0 (en) * 1985-09-17 1985-10-23 Biocompatibles Ltd Microcapsules
WO1994013266A1 (en) * 1992-05-29 1994-06-23 The Regents Of The University Of California Novel electrostatic process for manufacturing coated transplants and products
DE19644343A1 (en) * 1996-10-25 1998-04-30 Privates Inst Bioserv Gmbh Taste-neutral microcapsules, process for their preparation and their use
JPH1147581A (en) * 1997-07-30 1999-02-23 Takasago Internatl Corp Slow release capsule and its preparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389419A (en) * 1980-11-10 1983-06-21 Damon Corporation Vitamin encapsulation
US5427935A (en) * 1987-07-24 1995-06-27 The Regents Of The University Of Michigan Hybrid membrane bead and process for encapsulating materials in semi-permeable hybrid membranes
US5356636A (en) * 1991-12-14 1994-10-18 Basf Aktiengesellschaft Stable vitamin and/or carotenoid products in powder form, and the preparation thereof
EP0689834A2 (en) * 1994-07-01 1996-01-03 Willem Jacob Serfontein Sustained release food or feed supplement containing vitamins and minerals

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1115295A2 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007023223A1 (en) * 2005-08-25 2007-03-01 Virbac Sa Product for the preparation of enriched animal feed
WO2008087608A1 (en) * 2007-01-19 2008-07-24 The Iams Company Composition and method of stabilized sensitive ingredient
US11388914B2 (en) 2015-04-28 2022-07-19 Mars, Incorporated Process of preparing a wet pet food, wet pet food produced by the process and uses thereof
CN109265711A (en) * 2018-09-03 2019-01-25 胡权 A kind of preparation method of polymer particle
WO2020048435A1 (en) * 2018-09-03 2020-03-12 胡权 Polymer particles preparation method

Also Published As

Publication number Publication date
AU6165599A (en) 2000-04-17
JP2002525090A (en) 2002-08-13
WO2000018254A3 (en) 2000-05-25
BR9914070A (en) 2001-10-16
EP1115295A4 (en) 2004-12-15
AU758534B2 (en) 2003-03-27
EP1115295A2 (en) 2001-07-18
JP3605360B2 (en) 2004-12-22

Similar Documents

Publication Publication Date Title
US6146671A (en) Method and protecting heat-or oxygen-labile compounds to preserve activity and bioavailability
KR101175774B1 (en) Microcapsules having multiple shells and method for the preparation thereof
EP1492417B1 (en) Encapsulated agglomeration of microcapsules and method for the preparation thereof
EP0750854B1 (en) Process for encapsulating a core material with a polymer by high-pressure treatment
US5690990A (en) Process for encapsulating the flavor with colloid gel matrix
CN107484939B (en) Preparation method and application of casein-carboxylated chitosan self-assembled nano microcapsule
US8541040B2 (en) Process for producing protein microparticles
EP1371410A1 (en) Complex coacervates containing whey proteins
EP0494417B1 (en) Process for crosslinking gelatin and for incorporation a material therein
AU758534B2 (en) Method of protecting heat- or oxygen-labile compounds to preserve activity and bioavailability
US3560222A (en) Method of rapidly developing and stabilizing the cured color in comminuted meat and composition therefor
WO1997048288A1 (en) Method of encapsulation and product produced thereby
JP3164831B2 (en) Polysaccharide gel and method for producing the same
EP2490555A1 (en) Barrier composition
EP0372669B1 (en) Stabilized oil and fat powder
EP1377180A1 (en) Microcapsules
US5126328A (en) Process for crosslinking gelatin
JP2001078718A (en) Production of active ingredient preparation, active ingredient preparation and food or feed
US2912332A (en) Stabilized thiamine composition and method of enriching food products
González et al. Modification strategies of proteins for food packaging applications
GB1558590A (en) Method of producing albumin containing nutrient composition
CN117256670A (en) Preservative capsule for broccoli and preparation method thereof
Kamaldeen et al. IN-VITRO RELEASE KINECTICS OF CAROTENE CONTAINED IN MICROENCAPSULATED CARROT POWDERS

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase in:

Ref country code: JP

Ref document number: 2000 571780

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1999948490

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 61655/99

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 1999948490

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 61655/99

Country of ref document: AU